Literature DB >> 31334809

The diagnostic performance of rapid diagnostic tests and microscopy for malaria diagnosis in eastern Sudan using a nested polymerase chain reaction assay as a reference standard.

Zakya A Abdalla1, NourElhouda A Rahma1, Elhashimi E Hassan2, Tajeldin M Abdallah3, Hadeel E Hamad4, Samia A Omer4, Ishag Adam5.   

Abstract

BACKGROUND: Accurate diagnosis of malaria infection is essential for successful control and management of the disease. Both microscopy and rapid diagnostic tests (RDTs) are recommended for malaria diagnosis, however, RDTs are more commonly used. The aim of the current study was to assess the performance of microscopy and RDTs in the diagnosis of Plasmodium falciparum infection using a nested polymerase chain reaction (PCR) assay as the gold standard.
METHODS: A cross-sectional study was carried out in Kassala Hospital, eastern Sudan. A total of 341 febrile participants of all ages were recruited. Blood specimens were collected and malaria testing was performed using an RDT (SD Bioline Malaria Ag Pf), microscopy and nested PCR. The sensitivity, specificity, positive and negative predictive values (PPV and NPV, respectively) of microscopy and the RDT were investigated.
RESULTS: The prevalence of P. falciparum malaria infections in this study was 22.9%, 24.3% and 26.7% by PCR, microscopy and RDT, respectively. Compared with microscopy, the RDT had slightly higher sensitivity (80.7% vs 74.3%; p=0.442), equivalent specificity (89.3% vs 90.4%), a similar PPV (69.2% vs 69.8%) and a higher NPV (94.0% vs 92.2%).
CONCLUSIONS: The diagnostic performance of the RDT was better than that of microscopy in the diagnosis of P. falciparum malaria when nested PCR was used as the gold standard.
© The Author(s) 2019. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Plasmodium falciparumzzm321990 ; RDT; malaria; microscopy; nested PCR

Year:  2019        PMID: 31334809     DOI: 10.1093/trstmh/trz069

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  6 in total

1.  Anemia among Schoolchildren with Malaria and Soil-Transmitted Helminth Coinfections after Repeated Rounds of Mass Drug Administration in Muheza District, Tanzania.

Authors:  Billy Ngasala; Ferdinand Matata; Richard Mwaiswelo; Bruno P Mmbando
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

2.  Comparison of Rapid Diagnostic Test, Microscopy, and Polymerase Chain Reaction for the Detection of Plasmodium falciparum Malaria in a Low-Transmission Area, Jazan Region, Southwestern Saudi Arabia.

Authors:  Aymen M Madkhali; Ahmad Hassn Ghzwani; Hesham M Al-Mekhlafi
Journal:  Diagnostics (Basel)       Date:  2022-06-17

Review 3.  Malaria Rapid Diagnostic Tests: Literary Review and Recommendation for a Quality Assurance, Quality Control Algorithm.

Authors:  Michael J Kavanaugh; Steven E Azzam; David M Rockabrand
Journal:  Diagnostics (Basel)       Date:  2021-04-25

4.  Summary of discordant results between rapid diagnosis tests, microscopy, and polymerase chain reaction for detecting Plasmodium mixed infection: a systematic review and meta-analysis.

Authors:  Manas Kotepui; Kwuntida Uthaisar Kotepui; Giovanni De Jesus Milanez; Frederick Ramirez Masangkay
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

5.  A Deep Learning Approach for Segmentation of Red Blood Cell Images and Malaria Detection.

Authors:  Maria Delgado-Ortet; Angel Molina; Santiago Alférez; José Rodellar; Anna Merino
Journal:  Entropy (Basel)       Date:  2020-06-13       Impact factor: 2.524

6.  Evaluating the dual reactivity on SD bioline malaria rapid diagnosis tests as a potential indicator of high parasitemia due to Plasmodium falciparum.

Authors:  Roman Rodrigue Dongang Nana; Valerie Makoge; Ngum Lesley Ngum; Nathalie Amvongo-Adjia; Vineeta Singh; Roger Moyou Somo
Journal:  Pathog Glob Health       Date:  2021-07-26       Impact factor: 3.735

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.